Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jan;71(1):159–164. doi: 10.1172/JCI110745

Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid.

P D Winocour, R L Kinlough-Rathbone, M Richardson, J F Mustard
PMCID: PMC436848  PMID: 6848557

Abstract

Platelet survival in rabbits and rats is shortened by placing indwelling catheters in the aorta; this shortening appears to be at least partly related to the extent of vessel wall injury and platelet interaction with the repeatedly damaged wall. Treatment of rabbit platelets with plasmin and other proteolytic enzymes in vitro shortens their survival when they are returned to the circulation. Because platelets may be exposed to plasmin and other proteolytic enzymes in rabbits and rats with indwelling aortic catheters, we examined the effect of epsilon-aminocaproic acid (EACA) on platelet survival in rats. At a dose of 1 g/kg every 4 h, EACA significantly reduced whole blood fibrinolytic activity and prolonged the shortened platelet survival in rats with indwelling aortic catheters. Mean platelet survival for untreated rats with indwelling aortic catheters was 38.6 +/- 1.9 h, and for rats treated with EACA, 53.8 +/- 3.8 h. Scanning electron microscopy showed that the injured vessel wall of these animals was mainly covered with platelets and fibrin, whereas in control animals that did not receive EACA, the injured surface was mainly covered with platelets and little fibrin was observed. Thus shortened platelet survival during continuous vessel wall injury may result from the local generation of plasmin or the release of proteolytic enzymes at sites where platelets (and possibly leukocytes) interact with the vessel wall.

Full text

PDF
159

Images in this article

162Image
on p.162
162Image
on p.162
163Image
on p.163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., BULUK K. THROMBOPLASTIC AND FIBRINOLYTIC ACTIVITIES IN VESSELS OF ANIMALS. Circ Res. 1963 Sep;13:253–260. doi: 10.1161/01.res.13.3.253. [DOI] [PubMed] [Google Scholar]
  2. Abrahamsen A. F. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis. Scand J Haematol Suppl. 1968;3:1–53. [PubMed] [Google Scholar]
  3. Ardlie N. G., Packham M. A., Mustard J. F. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol. 1970 Jul;19(1):7–17. doi: 10.1111/j.1365-2141.1970.tb01596.x. [DOI] [PubMed] [Google Scholar]
  4. Buchanan M. R., Carter C. J., Hirsch J. Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damage. Blood. 1979 Dec;54(6):1369–1375. [PubMed] [Google Scholar]
  5. Caen J. P., Nurden A. T., Jeanneau C., Michel H., Tobelem G., Levy-Toledano S., Sultan Y., Valensi F., Bernard J. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med. 1976 Apr;87(4):586–596. [PubMed] [Google Scholar]
  6. Cazenave J. P., Packham M. A., Mustard J. F. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med. 1973 Dec;82(6):978–990. [PubMed] [Google Scholar]
  7. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost. 1980 Jun 18;43(2):77–89. [PubMed] [Google Scholar]
  8. Glick R., Green D., Ts'ao C., Witt W. A., Yu A. T., Raimondi A. J. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery. 1981 Oct;9(4):398–401. [PubMed] [Google Scholar]
  9. Greenberg J. P., Packham M. A., Guccione M. A., Rand M. L., Reimers H. J., Mustard J. F. Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase. Blood. 1979 May;53(5):916–927. [PubMed] [Google Scholar]
  10. Greenberg J., Packham M. A., Cazenave J. P., Reimers H. J., Mustard J. F. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest. 1975 Apr;32(4):476–484. [PubMed] [Google Scholar]
  11. Groves H. M., Kinlough-Rathbone R. L., Richardson M., Moore S., Mustard J. F. Platelet interaction with damaged rabbit aorta. Lab Invest. 1979 Feb;40(2):194–200. [PubMed] [Google Scholar]
  12. Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N Engl J Med. 1972 Nov 16;287(20):999–1005. doi: 10.1056/NEJM197211162872001. [DOI] [PubMed] [Google Scholar]
  13. Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N Engl J Med. 1972 Nov 16;287(20):999–1005. doi: 10.1056/NEJM197211162872001. [DOI] [PubMed] [Google Scholar]
  14. Kinlough-Rathbone R. L., Reimers H. J., Mustard J. F., Packham M. A. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science. 1976 Jun 4;192(4243):1011–1012. doi: 10.1126/science.1273582. [DOI] [PubMed] [Google Scholar]
  15. Meuleman D. G., Vogel G. M., van Delft A. M. Effects of intra-arterial cannulation on blood platelet consumption in rats. Thromb Res. 1980 Oct 1;20(1):45–55. doi: 10.1016/0049-3848(80)90055-9. [DOI] [PubMed] [Google Scholar]
  16. Moroz L. A., Gilmore N. J. A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin. Blood. 1975 Oct;46(4):543–553. [PubMed] [Google Scholar]
  17. Morrison J., Coromilas J., Munsey D., Robbins M., Zema M., Chiaramida S. U., Reiser P., Scherr L. Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man. Circulation. 1980 Aug;62(2):277–287. doi: 10.1161/01.cir.62.2.277. [DOI] [PubMed] [Google Scholar]
  18. Ohlsson K., Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem. 1974 Mar 1;42(2):519–527. doi: 10.1111/j.1432-1033.1974.tb03367.x. [DOI] [PubMed] [Google Scholar]
  19. Ordinas A., Maragall S., Castillo R., Nurden A. T. A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver. Thromb Res. 1978 Aug;13(2):297–302. doi: 10.1016/0049-3848(78)90018-x. [DOI] [PubMed] [Google Scholar]
  20. Packham M. A., Guccione M. A., Kinlough-Rathbone R. L., Mustard J. F. Platelet sialic acid and platelet survival after aggregation by ADP. Blood. 1980 Nov;56(5):876–880. [PubMed] [Google Scholar]
  21. Reimers H. J., Kinlough-Rathbone R. L., Cazenave J. P., Senyi A. F., Hirsh J., Packham M. A., Mustard J. F. In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost. 1976 Feb 29;35(1):151–166. [PubMed] [Google Scholar]
  22. Scheffel U., McIntyre P. A., Evatt B., Dvornicky J. A., Natarajan T. K., Bolling D. R., Murphy E. A. Evaluation of indium-111 as a new high photon yield gamma-emitting "physiological" platelet label. Johns Hopkins Med J. 1977 Jun;140(6):285–293. [PubMed] [Google Scholar]
  23. Weily H. S., Genton E. Altered platelet function in patients with prosthetic mitral valves. Effects of sulfinpyrazone therapy. Circulation. 1970 Nov;42(5):967–972. doi: 10.1161/01.cir.42.5.967. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES